Provided by Tiger Fintech (Singapore) Pte. Ltd.

BAIYUNSHAN PH

18.020
-0.060-0.33%
Volume:582.51K
Turnover:10.52M
Market Cap:29.30B
PE:9.44
High:18.110
Open:18.150
Low:17.980
Close:18.080
52wk High:18.940
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.11
T/O Rate:0.26%
Dividend:0.88
Dividend Rate:4.86%
EPS(LYR):1.909
ROE:7.46%
ROA:2.60%
PB:0.71
PE(LYR):9.44
PS:0.35

Loading ...

BAIYUNSHAN PH (00874) Subsidiary Receives Drug Supplementary Application Approval Certificates

Stock News
·
Sep 16

Baiyunshan Pharmaceutical Gets Green Light to Proceed to Phase II of BYS10 Tablets Trial

MT Newswires Live
·
Sep 16

Guangzhou Baiyunshan (SEHK:874): Exploring Its Valuation After a Year of Steady Share Price Gains

Simply Wall St.
·
Sep 14

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation

Stock News
·
Sep 03

Baiyunshan Pharma Gets Nod to Make Amendments to Two Antibiotics

MT Newswires Live
·
Sep 02

BAIYUNSHAN PH (00874): Subsidiary Baiyunshan Hanfang Receives Marketing Authorization for Structured Triglycerides Chemical Raw Material

Stock News
·
Aug 29

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Sells Fourth Batch of Additional Basic Assets to Xingzheng Asset Management

Stock News
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Disposals of Accounts Receivable

THOMSON REUTERS
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Confirm Disposal of Fourth New Underlying Assets of Gp Corp for RMB502 Mln

THOMSON REUTERS
·
Aug 28

BAIYUNSHAN PH (00874): Completes Private Fund Registration

Stock News
·
Aug 19

Traditional Medicine Sector Under Pressure as Baiyunshan Faces Performance Challenges

Deep News
·
Aug 19

Baiyunshan Pharma's H1 Profit Slips 1%, Revenue Rises 2%; Hong Kong Shares Up 4%

MT Newswires Live
·
Aug 18

Hong Kong Stock Movement | BAIYUNSHAN PH (00874) Surges Nearly 5% as H1 Net Profit Declines 1.31% YoY While Health Segment Shows Strong Performance

Stock News
·
Aug 18

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Executive Director of Ninth Board of Directors

Stock News
·
Aug 15

BAIYUNSHAN PH (00874) to Distribute Interim Dividend of HK$0.4399 Per Share on September 26

Stock News
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - Proposes to Appoint Chen Jiehui as Executive Director of 9TH Session

THOMSON REUTERS
·
Aug 15

BAIYUNSHAN PH (00874) Reports First Half Results with Net Profit of ~2.516 Billion Yuan, Down 1.31% YoY

Stock News
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - to Pay an Interim Cash Dividend of RMB0.40 per Share

THOMSON REUTERS
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - Hy Operating Revenue RMB41.83 Bln

THOMSON REUTERS
·
Aug 15

Baiyunshan Pharmaceutical Subsidiary to Issue Medium-Term, Short-Term Securities

MT Newswires Live
·
Jul 28